Recommended

Pharmalot
Pharmalot February 3, 2025

STAT Plus: Pharmalittle: We’re reading about tariffs’ effect on drug costs, a scrapped vaccine plant expansion, and more

By Ed Silverman

Pharmalot
Pharmalot January 31, 2025

STAT Plus: Up and down the ladder: The latest comings and goings

By Ed Silverman

advertisement

Pharmalot
Pharmalot January 31, 2025

STAT Plus: Pharmalittle: We’re reading about FDA OK for Vertex non-opioid pain drug, vaccine advisory committee, and more

By Ed Silverman

Pharmalot
Pharmalot January 30, 2025

STAT Plus: Pharmalittle: We’re reading about the RFK Jr. confirmation hearings, CMS plans for drug-pricing talks, and more

By Ed Silverman

Pharmalot
Pharmalot January 29, 2025

STAT Plus: Pharmalittle: We’re reading about a Super Bowl ad for compounded obesity drugs, a PEPFAR waiver, and more

By Ed Silverman

Subscriber Picks